Sutro Biopharma (STRO) PT Lowered to $20 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts STRO Hot Sheet
Price: $21.91 -0.59%
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Rating Summary:
14 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Join SI Premium – FREE
H.C. Wainwright analyst Andrew Fein lowered the price target on Sutro Biopharma (NASDAQ: STRO) to $20.00 (from $30.00) while maintaining a Buy rating.
You May Also Be Interested In
- Bernstein SocGen Group Upgrades Analog Devices (ADI) to Outperform
- Kingsoft Cloud (KC) PT Raised to $17.70 at Jefferies
- Morgan Stanley Upgrades Suncor Energy (SU) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
